| Bioactivity | Erlotinib-d6 (CP-358774 D6) is a deuterium labeled Erlotinib (CP-358774). Erlotinib is a directly acting inhibitor EGFR tyrosine kinase inhibitor with an IC50 of 2 nM for human EGFR[1]. |
| Name | Erlotinib-d6 |
| CAS | 1034651-23-4 |
| Formula | C22H17D6N3O4 |
| Molar Mass | 399.47 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Moyer JD, et al. Induction of apoptosis and cell cycle arrest by CP-358,774, an inhibitor of epidermal growth factor receptor tyrosine kinase. Cancer Res. 1997, 57(21), 4838-4848. |
Erlotinib-d6
CAS: 1034651-23-4 F: C22H17D6N3O4 W: 399.47
Erlotinib-d6 (CP-358774 D6) is a deuterium labeled Erlotinib (CP-358774). Erlotinib is a directly acting inhibitor EGFR
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.